TICKERNERD
Menu
AHCOAHCOHealthcare · Medical Devices

AHCO Stock Forecast: AdaptHealth Corp. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$5.64
+4.55% on the day

The 7 Wall Street analysts covering AdaptHealth Corp. hold a median 12-month price target of $10 — +77.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 51 of 100 as at 22 Aug 2026 — in the upper half.

Market cap
$751.1M
Ticker Nerd rank
51 / 100
Median analyst target
$10
Analysts covering
7
Total return, dividends reinvested
1W
−3.0%
1M
−49.7%
YTD
−43.4%
1Y
−39.5%
From 52W high
−57.9%
From 52W low
+8.0%
$5
$13
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

AHCO stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores AdaptHealth Corp. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
51 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
93
Quality
77
Volatility
75
Value
68
Size
49
Momentum
41
Issuance
37
Revisions
29
Growth
24

Accruals (93): Reported profit is backed by cash, and the company is not expanding recklessly.

Growth (24): Sales and profits are flat, shrinking, or growing more slowly than they were.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

AHCO stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on AHCO, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$4$6$8$10$12$14Oct 25Jan 26Apr 26Jul 26AHCOHigh $10Median $10Low $7

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says7 analysts
7 Buy0 Hold0 Sell
Low $7Median $10High $10

The green dot is the last close — the median target sits +77.5% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 1 moved their price target up and 4 moved it down.

DateFirmActionRatingTarget
6 Aug 2026RBC CapitalMaintainsOutperform$15 → $8.00
6 Aug 2026UBSMaintainsBuy$14 → $10
5 Aug 2026Truist SecuritiesMaintainsBuy$14 → $9.00
21 July 2026JefferiesUpgradeBuy—
21 July 2026JefferiesUpgradeBuy$11 → $13
6 July 2026BairdMaintainsOutperform—
6 July 2026BairdMaintainsOutperform$18 → $15
11 May 2026RBC CapitalMaintainsOutperform—
6 May 2026Canaccord GenuityMaintainsBuy—
6 May 2026UBSMaintainsBuy—
13 Apr 2026Truist SecuritiesMaintainsBuy—
26 Feb 2026Leerink PartnersMaintainsOutperform—
6 Nov 2025Canaccord GenuityMaintainsBuy—
12 May 2025Truist SecuritiesMaintainsBuy—
8 May 2025RBC CapitalMaintainsOutperform—
27 Feb 2025BairdMaintainsOutperform—
26 Feb 2025Canaccord GenuityMaintainsBuy—
26 Feb 2025RBC CapitalMaintainsOutperform—
26 Feb 2025Truist SecuritiesMaintainsBuy—
13 Feb 2025UBSMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. AHCO appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

AHCO analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
−151.4%
Analysts raising
0
Analysts cutting
0
Fundamentals

AdaptHealth Corp. (AHCO) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
16.6×

Cheaper than 44% of US stocks

Price / sales
0.2×

Cheaper than 92% of US stocks

Price / book
0.5×

Cheaper than 85% of US stocks

EV / EBITDA
4.8×

Cheaper than 54% of US stocks

Growth & margins
Revenue growth (YoY)
12.7%

Higher than 58% of US stocks

Earnings growth (YoY)
−4.1%

Higher than 31% of US stocks

Gross margin
−12.1%

Higher than 4% of US stocks

Operating margin
0.8%

Higher than 47% of US stocks

Net margin
−6.8%

Higher than 22% of US stocks

Returns & dividend
Return on equity
−15.2%

Higher than 33% of US stocks

Return on assets
2.3%

Higher than 60% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

AHCO vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
AHCOAdaptHealth Corp.$751.1M
51
VREXVarex Imaging Corp.$775.9M
80
BBNXBeta Bionics, Inc.$838.7M
36
SSIISS Innovations International, Inc.$694.1M
17
INMDInMode Ltd.$865.7M
76
SIBNSI-BONE, Inc.$881.5M
72
CBLLCeribell, Inc.$897.7M
32

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own AdaptHealth Corp. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest AHCO news & analysis

ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health

PRNewsWire · 17 Aug 2026negative

Cathay Capital announced the launch of ReDream Brands, a new direct-to-consumer sleep health platform that combines four brands—cpap.com, The CPAP Shop, Lofta, and sleeping.com—to serve the cash-pay obstructive sleep apnea market across North America.

Why it matters — AHCO operates in the same sleep and CPAP space, so a consolidated direct-to-consumer platform could intensify competition in the cash-pay OSA market.

AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

GlobeNewsWire · 14 Aug 2026negative

A national class action law firm, Edelson Lechtzin LLP, has launched an investigation into data privacy claims arising from a data breach at AdaptHealth Corp. The firm is examining exposure of personal information tied to the breach.

Why it matters — The investigation signals potential legal and regulatory exposure for AdaptHealth related to the handling of customer personal data.

AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky

PRNewsWire · 12 Aug 2026negative

AdaptHealth Corp. reported second-quarter 2026 revenue of $740.3 million, below the roughly $847–$849 million consensus, and a GAAP loss of $0.99 per share versus expectations of approximately $0.15. Following the miss, shares fell as much as 26%, and Levi & Korsinsky issued a securities investigation notice regarding the company.

Why it matters — AHCO watchers would care because the revenue and earnings shortfall triggered a significant share-price drop and an announced securities investigation tied to the results.

AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth

MarketBeat · 11 Aug 2026positive

AdaptHealth has sold its diabetes unit as part of a strategic shift to focus more intently on its sleep, respiratory, and home medical equipment businesses, according to executives speaking at a Canaccord conference.

Why it matters — The divestiture signals a sharper strategic direction for AHCO, potentially allowing management to allocate more capital and resources toward its core growth areas of sleep and respiratory care.

Why AdaptHealth Stock Plummeted This Week

The Motley Fool · 9 Aug 2026negative

AdaptHealth reported a significant earnings miss in Q2, with sales also falling short of expectations. The company additionally lowered its fiscal performance targets for the year.

Why it matters — AHCO watchers would care because the second-quarter miss and downward revision of annual targets point to weaker-than-expected business performance.

FAQ

Frequently asked questions about AHCO stock

What is the AHCO stock price forecast for 2026-2027?

The 7 Wall Street analysts covering AdaptHealth Corp. have a median 12-month price target of $10, with estimates ranging from $7 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is AHCO stock a buy right now?

Of the 7 analysts covering AdaptHealth Corp., 7 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks AdaptHealth Corp. 51 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank AHCO?

As at 22 Aug 2026, AdaptHealth Corp. ranks 51 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (93 of 100).

Will AHCO stock go up?

No one can know that. What the data says: the median 12-month target from 7 analysts implies +77.5% from the last close, and Ticker Nerd's factor model ranks AdaptHealth Corp. 51 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the AHCO stock forecast for 2030?

No analyst covering AdaptHealth Corp. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for AHCO are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $7 to $10 over the next 12 months.

How has AHCO stock performed over the past year?

AdaptHealth Corp. returned -39.5% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does AdaptHealth Corp. do?

AdaptHealth Corp. is a national provider of home medical equipment, medical supplies, and healthcare-at-home solutions serving patients across all 50 states.

What is the latest news on AHCO?

The most recent item we track (PRNewsWire, 17 Aug 2026): "ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health". Cathay Capital announced the launch of ReDream Brands, a new direct-to-consumer sleep health platform that combines four brands—cpap.com, The CPAP Shop, Lofta, and sleeping.com—to serve the cash-pay obstructive sleep apnea market across North America.

Company

About AdaptHealth Corp.

AdaptHealth Corp. is a national provider of home medical equipment, medical supplies, and healthcare-at-home solutions serving patients across all 50 states. The company specializes in sleep therapy equipment and related services for individuals with obstructive sleep apnea, including CPAP and bi-PAP devices, as well as medical equipment and supplies for diabetes management, chronic respiratory conditions, wound care, and other chronic illnesses. Through a network of approximately 680 locations, AdaptHealth handles tens of thousands of daily equipment and supply deliveries to millions of patients annually. The company operates through two primary revenue streams: fixed monthly rentals of durable medical equipment such as hospital beds and oxygen concentrators, and recurring sales of consumable supplies like masks and diabetes management products. AdaptHealth provides comprehensive patient services including equipment setup, education, and ongoing support, along with automated resupply programs to ensure treatment continuity. The company primarily bills insurance providers, including Medicare and Medicaid, and generates revenue by serving as a critical link between healthcare facilities and patients requiring ongoing medical equipment and supplies in their homes.

CEO Ms. Suzanne M. Foster M.P.H. · 10,900 employees · United States · https://adapthealth.com